Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

93 (43%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2021-01-07 2021-02-12 131093
CINQAIR 10MG SOLUTION Resolved 2020-05-08 2020-09-03 114421
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-06-27 2019-08-29 87665
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-06-24 2021-07-09 141469
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2023-04-27 2023-06-09 190671
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2023-06-16 2023-08-18 195121
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-11-07 2020-05-29 98188
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-01-15 2021-05-06 131691
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2021-02-05 2021-04-29 133457
DOCETAXEL INJECTION 20MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1680
DOCETAXEL INJECTION 80MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1688
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2021-04-21 2021-05-20 137890
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2018-06-22 2018-10-11 52823
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-06-20 2023-10-19 195806
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-06-18 2020-06-25 118253
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-01-12 2023-10-06 180891
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-06-16 2023-07-05 195219
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2025-01-30 2025-04-24 249210
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2025-01-30 2025-03-20 249213
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-01-20 2022-04-21 153156
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DEFERASIROX 250MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103796
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-03-20 2025-03-20 253156
TEVA-DICLOFENAC EC 25MG TABLET (ENTERIC-COATED) Discontinued 2024-01-25 2024-01-26 217254
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-04-25 2025-04-25 255812
TEVA-DICLOFENAC SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2025-04-29 2025-04-29 256131
TEVA-DICLOFENAC-K 50MG TABLET Discontinued 2025-03-20 2025-03-20 253168
TEVA-DILTIAZEM CD 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81307
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-06-04 2019-06-04 85572
TEVA-DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-06-04 2019-06-04 85575
TEVA-DIVALPROEX 125MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97232
TEVA-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97235
TEVA-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97238
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117491
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117494
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
TEVA-EFAVIRENZ 600MG TABLET Discontinued 2025-04-29 2025-04-29 256134
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64855
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64858
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64861
TEVA-ENALAPRIL 16MG TABLET Discontinued 2018-10-19 2018-10-19 64866